Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostavasin in patients with critical limb ischemia
IRCT201207292220N4Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Vasostenoon in chronic limb-threatening ischemia (CLTI) and peripheral artery occlusion (PAD), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2008; status: completed.
02
Drugs
Vasostenoon
03
Conditions
chronic limb-threatening ischemia (CLTI)peripheral artery occlusion (PAD)
Beyond the preview
Go deeper on IRCT201207292220N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201207292220N4.